![The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220310052-gr5.jpg)
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
![Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0891584918307457-fx1.jpg)
Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect
![Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine | Scientific Reports Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-30796-w/MediaObjects/41598_2018_30796_Fig1_HTML.png)
Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine | Scientific Reports
![Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07701-8/MediaObjects/12885_2020_7701_Fig1_HTML.png)
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
![Cytarabine (1-β-D-Arabinofuranosylcytosine, NSC 63878, NSC 287459, U-19920A, CAS Number: 147-94-4) | Cayman Chemical Cytarabine (1-β-D-Arabinofuranosylcytosine, NSC 63878, NSC 287459, U-19920A, CAS Number: 147-94-4) | Cayman Chemical](https://www.caymanchem.com/images/catalog/screen/16069.png)
Cytarabine (1-β-D-Arabinofuranosylcytosine, NSC 63878, NSC 287459, U-19920A, CAS Number: 147-94-4) | Cayman Chemical
![Radiolytic activation of a cytarabine prodrug possessing a 2-oxoalkyl group: one-electron reduction and cytotoxicity characteristics - Organic & Biomolecular Chemistry (RSC Publishing) Radiolytic activation of a cytarabine prodrug possessing a 2-oxoalkyl group: one-electron reduction and cytotoxicity characteristics - Organic & Biomolecular Chemistry (RSC Publishing)](https://pubs.rsc.org/image/article/2009/ob/b816194a/b816194a-s1.gif)
Radiolytic activation of a cytarabine prodrug possessing a 2-oxoalkyl group: one-electron reduction and cytotoxicity characteristics - Organic & Biomolecular Chemistry (RSC Publishing)
![Marine Drugs | Free Full-Text | Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery | HTML Marine Drugs | Free Full-Text | Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery | HTML](https://www.mdpi.com/marinedrugs/marinedrugs-13-04967/article_deploy/html/images/marinedrugs-13-04967-g001-1024.png)
Marine Drugs | Free Full-Text | Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery | HTML
![Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/a23f698c-59a5-4180-9cc7-94b5fb20e70b/emmm201910419-abs-0001-m.jpg)
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
![Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy](https://c8.alamy.com/comp/KXYGR0/cytarabine-cytosine-arabinoside-ara-c-chemotherapy-drug-molecule-used-KXYGR0.jpg)
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy
Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
![Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07701-8/MediaObjects/12885_2020_7701_Fig5_HTML.png)
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
![Cytarabine (cytosine Arabinoside, Ara-C) Chemotherapy Drug Molecule... Stock Photo, Picture And Royalty Free Image. Image 93261187. Cytarabine (cytosine Arabinoside, Ara-C) Chemotherapy Drug Molecule... Stock Photo, Picture And Royalty Free Image. Image 93261187.](https://previews.123rf.com/images/molekuul/molekuul1801/molekuul180100147/93261187-cytarabine-cytosine-arabinoside-ara-c-chemotherapy-drug-molecule-used-in-treatment-of-acute-myeloid-.jpg)